FDA快速通道认证-话题@MedSci

#FDA快速通道认证#

4篇内容 | 1324人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1389075, encodeId=283413890e51a, content=<a href='/topic/show?id=7e96e30909' target=_blank style='color:#2F92EE;'>#FDA快速通道认证#</a>, objectTitle=AB201作为COVID-19的潜在疗法：已获美国FDA快速通道认证, objectType=article, longId=203708, objectId=2056203e0870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2056203e0870, replyNumber=0, likeNumber=83, createdTime=2020-11-26, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2056203e0870, moduleTitle=AB201作为COVID-19的潜在疗法：已获美国FDA快速通道认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2056203e0870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389074, encodeId=6e2713890e46b, content=<a href='/topic/show?id=7e96e30909' target=_blank style='color:#2F92EE;'>#FDA快速通道认证#</a>, objectTitle=黑色素瘤癌症疫苗Seviprotimut-L，获得FDA快速通道认证, objectType=article, longId=196490, objectId=42171964903c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42171964903c, replyNumber=0, likeNumber=76, createdTime=2020-06-27, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42171964903c, moduleTitle=黑色素瘤癌症疫苗Seviprotimut-L，获得FDA快速通道认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42171964903c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389073, encodeId=c0d813890e34d, content=<a href='/topic/show?id=7e96e30909' target=_blank style='color:#2F92EE;'>#FDA快速通道认证#</a>, objectTitle=T细胞疗法DSG3-CAART获得FDA快速通道认证：用于治疗寻常型粘膜天疱疮, objectType=article, longId=193723, objectId=bd8a193e2301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd8a193e2301, replyNumber=0, likeNumber=79, createdTime=2020-05-09, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd8a193e2301, moduleTitle=T细胞疗法DSG3-CAART获得FDA快速通道认证：用于治疗寻常型粘膜天疱疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd8a193e2301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1389072, encodeId=100613890e2ad, content=<a href='/topic/show?id=7e96e30909' target=_blank style='color:#2F92EE;'>#FDA快速通道认证#</a>, objectTitle=PR006获得美国FDA快速通道认证，以减慢GRN突变导致额颞痴呆的疾病进展, objectType=article, longId=190778, objectId=a7d4190e78cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7d4190e78cb, replyNumber=0, likeNumber=98, createdTime=2020-03-26, rootId=0, userName=12498568m50暂无昵称, userId=1e452500029, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7d4190e78cb, moduleTitle=PR006获得美国FDA快速通道认证，以减慢GRN突变导致额颞痴呆的疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7d4190e78cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FDA快速通道认证

2020-05-29

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#FDA快速通道认证#

AB201作为COVID-19的潜在疗法：已获美国FDA快速通道认证

2020-11-26

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#FDA快速通道认证#

黑色素瘤癌症疫苗Seviprotimut-L，获得FDA快速通道认证

2020-06-27

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#FDA快速通道认证#

T细胞疗法DSG3-CAART获得FDA快速通道认证：用于治疗寻常型粘膜天疱疮

2020-05-09

12498568m50暂无昵称 (审核中...)

前往app查看评论内容

#FDA快速通道认证#

PR006获得美国FDA快速通道认证，以减慢GRN突变导致额颞痴呆的疾病进展

2020-03-26

科室
- - 订阅+
  - 更多科室
工具
服务